Prestige Brings In New Management As It Consolidates CDMO Control

Prestige Biologics Gets New CEO As Prestige Biopharma Becomes Largest Shareholder

 
• By Dave Wallace

Prestige Biopharma says it is acting to “consolidate group competitiveness” by taking an increased share in Prestige Biologics, at the same time as a new CEO was appointed for the CDMO.

Percentage increase neon sign hand grab
Prestige Biopharma has grabbed a larger stake in Prestige Biologics • Source: Shutterstock

More from Strategy

More from Business